-
1.
Dynamics of uptake and excretion of Sm-153-oxabifor in patients with bone metastases in the performance of radionuonuclide therapy
-
(«Radiation and Risk», 2007, vol. 16, No. 2-4)
-
Dolya О.P.1, Klepov А.N.1, Кrylov V.V., Drozdovsky B.Ya., Маtusevich Е.S.1
«Radiation and Risk», 2007, vol. 16, No. 2-4, pp.39-47
«Radiation and Risk», 2007, vol. 16, No. 2-4, pp.39-47
Authors ...
-
2.
Estimation of exposure of metastatic foci and critical bone structures in the perfor-mance of radionuclide therapy with Sm-153-oxabifor
-
(«Radiation and Risk», 2007, vol. 16, No. 2-4)
-
Dolya О.P.1, Klepov А.N.1, Кrylov V.V., Drozdovsky B.Ya., Маtusevich Е.S1,
Oleinik N.А., Spichenkova О.N.
«Radiation and Risk», 2007, vol. 16, No. 2-4, pp.48-60
«Radiation and Risk», 2007, vol. ...
